UMeWorld Inc. (OTC: UMEWF) is advancing global sustainability and health through two key initiatives: Verdant Biofuel, a renewable energy platform converting waste oils and abundant vegetable waste into high-value biofuels, and DAGola®, a functional nutrition brand pioneering the world's first clinically validated 'smart' cooking oils.
Our mission is to foster those scalable, high-margin verticals to address urgent global needs across energy and health. Through technological innovation, regulatory alignment and a dual-market strategy, UMeWorld is positioned for rapid expansion, strong capital efficiency, global impact, and furthering long-term shareholder value.
Our aggressive commercialization is underpinned by our proprietary enzymatic technology, which creates a moat while engaging three billion-dollar-plus markets: the $25B edible oil sector, the $150B functional foods industry, and the $200B renewable energy market – all powered by a single, scalable innovation.
Dual-Vertical Model
One proven enzymatic platform powers two core verticals in functional nutrition (DAGola) and clean energy (Verdant Biofuel).
De-Risked Technology
Commercially validated through DAGola production; the same enzymatic process in use can be scaled industrially for biofuel. Our technology provides us a substantial competitive moat for the foreseeable future and potential licensing opportunities for other industrial uses.
Mandated Demand
Verdant Biofuel targets legally required SAF adoption under U.S., EU and other regional regulations, ensuring structural, multi-decade demand in various major markets.
Rapid Global Scaling
DAGola U.S. distribution via Amazon and Walmart is live, alongside live distribution in China. Additional regions shall follow in a scaled launch. Verdant Biofuel shall be scaled in a similar manner following the production of EnzyFuel™.
Massive Market Potential
Combined total addressable markets exceeding $1 trillion by 2030, which we target with scalable, high-margin solutions.
Shareholder Value Focus
Capital-light, revenue-generating, and built for sustainable growth across multiple high-impact verticals as we align for, and maximize, long-term shareholder value.
Combined total addressable market across functional nutrition and renewable fuels by 2030.
Target production capacity for Project Verdant, expanding from biodiesel production to full-scale SAF output. Phase 1 (50,000 MT) is now underway.
Number of people suffering from metabolic syndrome globally, with an estimated 1/3rd of American adults falling under this figure - representing a target demographic for DAGola.
Forward-Looking Statements: Certain statements on this website are forward-looking and subject to risks and uncertainties that may cause actual results to differ materially to those projected herein. UMeWorld Inc. undertakes no obligation to update any forward-looking statements, and information provided here does not constitute an offer to sell or a solicitation to buy any securities, and should not be construed as such.
